The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses.
Eubacterium rectale
Mediterraneibacter tenuis
RA clinical indices
RA‐originated gut microbial biobank (RAGMB)
core microbial species
inflammatory and immune responses
rheumatoid arthritis (RA)
Journal
iMeta
ISSN: 2770-596X
Titre abrégé: Imeta
Pays: Australia
ID NLM: 9918350383706676
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
received:
03
09
2024
revised:
15
09
2024
accepted:
17
09
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
21
10
2024
Statut:
epublish
Résumé
Gut microbiota dysbiosis has been implicated in rheumatoid arthritis (RA) and influences disease progression. Although molecular and culture-independent studies revealed RA patients harbored a core microbiome and had characteristic bacterial species, the lack of cultured bacterial strains had limited investigations on their functions. This study aimed to establish an RA-originated gut microbial biobank (RAGMB) that covers and further to correlates and validates core microbial species on clinically used and diagnostic inflammation and immune indices. We obtained 3200 bacterial isolates from fecal samples of 20 RA patients with seven improved and 11 traditional bacterial cultivation methods. These isolates were phylogenetically identified and selected for RAGMB. The RAGMB harbored 601 bacterial strains that represented 280 species (including 43 novel species) of seven bacterial phyla. The RAGMB covered 93.2% at species level of medium- and high-abundant (relative abundances ≥0.2%) RA gut microbes, and included four rare species of the phylum
Identifiants
pubmed: 39429876
doi: 10.1002/imt2.242
pii: IMT2242
pmc: PMC11487554
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e242Informations de copyright
© 2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.